Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks under $50 to invest in. Barclays maintained an Overweight rating on Teva Pharmaceutical Industries Limited (NYSE ...

Key Insights Given the large stake in the stock by institutions, Teva Pharmaceutical Industries' stock price might ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) stock is trading higher on Wednesday after the company’s first-quarter 2025 financial results. Here are the details. Teva reported revenue of $3.89 ...

Teva Pharmaceutical stock has rebounded from lows, driven by debt reduction, halted price deflation in generics, and new product launches, making it a strong buy. Teva's innovative branded drugs and ...

Teva Pharmaceutical Industries Limited’s TEVA stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since the end of October. It achieved the golden cross in mid-September.

Goldman Sachs revealed a slew of stocks that the firm says are extremely compelling. The Wall Street investment bank said ...

Teva's stock has risen 105% in two years, outperforming the S&P 500, but it is no longer a bargain at $17.50 per share. The company's focus on debt reduction has been successful, with net debt falling ...

Teva’s turnaround plan is finally starting to pay off. The smart money is paying close attention. Teva stock remains dirt-cheap with a low single-digit P/E multiple and plenty of underrated, growthy ...

The person behind the modification was JPMorgan Chase analyst Chris Schott, who pushed up his Teva stock recommendation one notch from neutral to overweight (read: buy). He also bumped his price ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the stocks that Jim Cramer shared takes on, along with ...